Ztlido - (1.80% ; Topical Patch)

Generic Name	Lidocaine	Innovator	Scilex
Dosage	1.80% ; Topical Patch	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	ZTLIDO contains lidocaine, an amide local anesthetic, and is indicated for relief of pain associated with post-herpetic neuralgia (PHN).
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
***** **** ********	*** \ *********	*** **, ****	*******	****	*** ****** *** **, ****

Chronology Of Events